Study of STLX-2012 in Healthy Volunteers

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The purpose of this research is to establish the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of a single IV dose of STLX-2012.
Epistemonikos ID: 843e118398bc3aae3b1a45103b7ecba2644094fe
First added on: Nov 18, 2025